.-We have previously shown that the cyclooxygenase (COX)-2/PGE2 pathway plays a key role in VEGF production in gastric fibroblasts. Recent studies have identified three PGE synthase (PGES) isozymes: cytosolic PGES (cPGES) and microsomal PGES (mPGES)-1 and -2, but little is known regarding the expression and roles of these enzymes in gastric fibroblasts. Thus we examined IL-1-stimulated mPGES-1 and cPGES mRNA and protein expression in gastric fibroblasts by quantitative PCR and Western blot analysis, respectively, and studied both their relationship to COX-1 and -2 and their roles in PGE2 and VEGF production in vitro. IL-1 stimulated increases in both COX-2 and mPGES-1 mRNA and protein expression levels. However, COX-2 mRNA and protein expression were more rapidly induced than mPGES-1 mRNA and protein expression. Furthermore, MK-886, a nonselective mPGES-1 inhibitor, failed to inhibit IL-1-induced PGE2 release at the 8-h time point, while totally inhibiting PGE2 at the later stage. However, MK-886 did inhibit IL-1-stimulated PGES activity in vitro by 86.8%. N-(2-cyclohexyloxy-4-nitrophenyl)-methanesulfonamide (NS-398), a selective COX-2 inhibitor, totally inhibited PGE2 production at both the 8-h and 24-h time points, suggesting that COX-2-dependent PGE2 generation does not depend on mPGES-1 activity at the early stage. In contrast, NS-398 did not inhibit VEGF production at 8 h, and only partially at 24 h, whereas MK-886 totally inhibited VEGF production at each time point. These results suggest that IL-1-induced mPGES-1 protein expression preferentially coupled with COX-2 protein at late stages of PGE2 production and that IL-1-stimulated VEGF production was totally dependent on membrane-associated proteins involved in eicosanoid and glutathione metabolism (MAPEG) superfamily proteins, which includes mPGES-1, but was partially dependent on the COX-2/PGE2 pathway.interleukin-1; MK-886; MAPEG superfamily; prostaglandin E synthase activity PROSTAGLANDINS (PGs), potent lipid mediators during pain and inflammation, are derived through the cyclooxygenase (COX)-catalyzed conversion of arachidonic acid to PGH2 (5,9,25,33). PGs also play a physiological role in maintaining the integrity of the gastric mucosa, in which COX-1 is constitutively expressed (12,30,35). In addition, we have shown in previous studies that COX-2 is expressed in fibroblasts beneath the gastric ulcer bed in humans (20,45) and that N-(2-cyclohexyloxy-4-nitrophenyl)-methanesulfonamide (NS-398), a selective COX-2 inhibitor, delays gastric ulcer healing in mice (21), suggesting that COX-2 is also important for gastric mucosal integrity (7,31). Furthermore, in a more recent study, we were able to show in vitro that gastric fibroblasts express COX-2 and produce COX-2/PGE2-dependent VEGF in response to IL-1, a proinflammatory cytokine (20).Recently, three different PGE synthase (PGES) isozymes have been identified: cytosolic PGES (cPGES) (44), microsomal PGES (mPGES)-1 (11, 18, 23), and mPGES-2 (22, 43). cPGES, is constitutively and ubiquitously ex...